Drospirenone Female Sex Hormones for Preventing Pregnancy CAS 67392-87-4
- Manufacturer: Dewael
- Product Assay: 99%+
- Appearance:White or Almost White Crystalline Powder
- Place of Origin: China
- Certification: SGS,ISO9001,GMP
- Minimum Order Quantity: 10g
- Packaging Details: Discreet ways of packing for Customs pass guaranteed
- Delivery Time: Within 12 hours after receiving your payment
- Payment Terms: Western Union, MoneyGram,Bitcoin,Bank Transfer
- Shipping: EMS,DHL,Fedex,UPS,TNT and so on.
- Policy: Re-Shipping Policy
- Supply ability: 500-600kg/month
Drospirenone Female Sex Hormones for Preventing Pregnancy CAS 67392-87-4
Basic Info.
Product Name: Drospirenone
Synonyms: arbolactone
CAS: 67392-87-4
MF: C24H30O3
MW: 366.49
EINECS: 266-679-2
Mp: 196-200°C
Alpha: -180°(c=0.5, chloroform)
Storage temp: -20°C Freezer
Appearance: Off-White Crystalline Powder
Product Description:
At present, the only similar characteristics with natural progesterone progesterone progesterone structure with traditional oral contraceptives contained completely different, it is closer to natural progesterone. Drospirenone addition to anti-androgen effect, but also has the role of Salt corticosteroids can prevent sodium and water retention in the body. Not only has excellent contraceptive effect, there will be many positive effects on women’s health. For example, to reduce the acne, skin is more smooth, effective control of body weight.
Product Application:
Drospirenone is an ingredient in some birth control pills and hormone replacement therapy. In combination with ethinyl estradiolit is used as contraception, and for women who want contraception it is also approved by the U. S. Food and Drug Administration(FDA) to treat moderate acne and premenstrual dysphoric disorder.
Medical uses
Drospirenone is an ingredient in some birth control pills and hormone replacement therapy. In combination with ethinylestradiol it is used as contraception, and for women who want contraception it is also approved by the U.S. Food and Drug Administration (FDA) to treat moderate acne and premenstrual dysphoric disorder.
Drospirenone is 8–10 times more potent as an antimineralocorticoid relative to spironolactone (3 mg drospirenone is equivalent to about 20–25 mg spironolactone in this regard. It is more potent as an antiandrogen relative to spironolactone also but is less potent relative to cyproterone acetate, having about one-third the potency of this drug. Progestogenic, antimineralocorticoid, and mild antiandrogenic effects have been observed in humans during treatment with drospirenone at a dosage range of 0.5 to 4 mg per day orally. The antimineralocorticoid properties exhibited by drospirenone promote sodium excretion and prevent water retention.
———————————————————————————————————————————————————————————————————————————————————————-
Contact Now
Reviews
There are no reviews yet.